Please use a PC Browser to access Register-Tadawul
Get It
AtriCure shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.
AtriCure, Inc. ATRC | 29.54 | -1.09% |
